USE OF HSP90 INHIBITORS TO OVERCOME TRASTUZUMAB RESISITANCE IN THE MINOR VARIANT OF HER2 P95HER2 IN BREAST CANCER
Loading...
Links to Files
Permanent Link
Author/Creator
Author/Creator ORCID
Date
2018-11-30
Type of Work
Department
Department of Biology
Program
Biomedical Science